The stock price for Generation Bio Co (GBIO) currently stands at $6.39. The stock experienced a substantial increase in the last session, hitting $90.0 after starting at $6.49. The stock’s lowest price was $40.0 before closing at $4.05.
Generation Bio Co experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $29.40 on 08/29/24, while the lowest price for the same period was registered at $3.00 on 06/27/25.
52-week price history of GBIO Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Generation Bio Co’s current trading price is -78.25% away from its 52-week high, while its distance from the 52-week low is 112.82%. The stock’s price range during this period has spanned from $3.00 to $29.40. In the Healthcare sector, the Generation Bio Co’s shares surpassed a trading volume of approximately 6.41 million for the day, which was noticeably higher compared to the average daily volume of 9.0.18 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Generation Bio Co (GBIO) has experienced a quarterly rise of 62.80% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 42.86M and boasts a workforce of 115 employees.
A Closer Look at Analysts’ Ratings for Generation Bio Co
As of right now, 2 analysts are rating Generation Bio Co as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.03, with a change in price of +0.96. Similarly, Generation Bio Co recorded 186,875 in trading volume during the last 100 days, posting a change of +18.60%.
Examining GBIO’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for GBIO stands at 1.58. Similarly, the long-term debt-to-equity ratio is also 1.40.
GBIO Stock Stochastic Average
Today, Generation Bio Co’s raw stochastic average for the past 50 days stands at 90.69%, indicating a rise from the raw stochastic average of the last 20 days, which was 87.84%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 36.84% and 21.24% respectively.
GBIO Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -72.80%. However, over the past six months, we’ve seen a weaker performance of 1.48%. The price of GBIO fallen by 50.07% over the last 30 days. And in the last five days, it has surged by 49.37%.
